Article
A novel STAT5B mutation causing GH insensitivity syndrome associated with hyperprolactinemia and immune dysfunction in two male siblings.
European journal of endocrinology - 1 Aug 2010
Pugliese-Pires Patricia N, Tonelli Carlos A, Dora Jose M, Silva Paulo C A, Czepielewski Mauro, Simoni Genoir, Arnhold Ivo J P, Jorge Alexander A L
Abstract excerpt
BACKGROUND: GH insensitivity (GHI) syndrome caused by STAT5B mutations was recently reported, and it is characterized by extreme short stature and immune dysfunction. Treatment with recombinant human IGF1 (rhIGF1) is approved for patients with GHI, but the growth response to this therapy in patients with STAT5B mutations has not been reported. OBJECTIVES: To report the clinical features, molecular findings, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
